A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
Usher syndrome is a genetic disorder causing neurosensory hearing loss and blindness from retinitis pigmentosa (RP). Adaptive techniques such as braille, digital and optical magnifiers, mobility training, cochlear implants or other assistive listening devices are indispensable for reducing disabilit...
Saved in:
Published in | Frontiers in cellular neuroscience Vol. 14; p. 183 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Lausanne
Frontiers Research Foundation
09.07.2020
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Usher syndrome is a genetic disorder causing neurosensory hearing loss and blindness from retinitis pigmentosa (RP). Adaptive techniques such as braille, digital and optical magnifiers, mobility training, cochlear implants or other assistive listening devices are indispensable for reducing disability. However, there is currently no treatment to reduce or arrest sensory cell degeneration. There are several classes of treatments for Usher syndrome being investigated. The present article reviews the progress that research has made toward delivering commercial options for patients with Usher syndrome. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Specialty section: This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience Reviewed by: Nicholas D. Mazarakis, Imperial College London, United Kingdom; Wei Xiong, Tsinghua University, China Edited by: Raymond Ching-Bong Wong, Centre for Eye Research Australia, Australia |
ISSN: | 1662-5102 1662-5102 |
DOI: | 10.3389/fncel.2020.00183 |